Literature DB >> 1327173

Cytomegalovirus disease in AIDS: the Edinburgh experience.

I Cheong1, P J Flegg, R P Brettle, P D Welsby, S M Burns, B Dhillon, C L Leen, J A Gray.   

Abstract

Retrospective analysis of medical records of 557 HIV positive patients (including 113 with AIDS) revealed 17 patients with an antemortem clinical diagnosis of cytomegalovirus (CMV) disease. This group comprised 7 injection drug users (2 male and 5 female) and 10 homosexual men. Males were significantly older than females, and homosexual men were significantly older than drug users at the time of diagnosis of CMV. All 17 patients had evidence of retinitis, and 6 also had evidence of extraocular disease. CMV retinitis was the AIDS defining diagnosis in two patients, and the attack rate of CMV in all AIDS patients progressively increased with time, with a 3-year CMV-free survival of 57%. Fifteen patients with CMV disease had evidence of previous CMV infection (CMV IgG positive), with 7 also having a positive CMV IgM and 10 a positive viral culture. The mean CD4+ lymphocyte count at diagnosis of CMV was 17 cells/mm3, compared with 68 cells/mm3 at diagnosis of AIDS. Therapy was unsatisfactory, often being complicated by marrow suppression. Relapse occurred in 11 patients after initial improvement but despite this only 3 patients died with severe visual impairment. The mean survival after a diagnosis of CMV was 10.5 months. This study confirms that disease caused by CMV is usually a late manifestation of AIDS, and the increasing prevalence among patients with AIDS implies that, the longer the survival, the greater the risk of disease. Frequent fundoscopy in HIV positive patients is of paramount importance particularly in patients who have a CD4+ lymphocyte count of less than 100 cells/mm3.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327173     DOI: 10.1177/095646249200300504

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  6 in total

1.  Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

Authors:  C Binquet; F Saillour; N Bernard; M B Rougier; F Leger; F Bonnal; F Dabis
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

2.  Effect of CMV serology and CMV disease on AIDS morbidity and mortality.

Authors:  R B Laing; R P Brettle; C L Leen
Journal:  Infection       Date:  1997 Jul-Aug       Impact factor: 3.553

Review 3.  The management of cytomegalovirus retinitis in AIDS.

Authors:  B Dhillon
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638

4.  Cytomegalovirus retinitis in patients with AIDS in Europe. AIDS in Europe Study Group.

Authors:  M Burke; I Yust; C Katlama; N Vardinon; N Clumeck; A J Pinching; B Ledergerber; J M Gatell; A Chiesi; S E Barton; J D Lundgren; C Pedersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

5.  Clinical utility of cytomegalovirus urine cultures for ophthalmic care in patients with HIV.

Authors:  M M Gellrich; E Baumert; J A Rump; P Vaith; F T Hufert; L L Hansen
Journal:  Br J Ophthalmol       Date:  1996-09       Impact factor: 4.638

6.  Economic evaluation of treatment administration strategies of ganciclovir for cytomegalovirus retinitis in HIV/AIDS patients in Thailand: a simulation study.

Authors:  Kanlaya Teerawattananon; Saniorn Iewsakul; Chawewan Yenjitr; Somsanguan Ausayakhun; Watanee Yenjitr; Miranda Mugford; Yot Teerawattananon
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.